4/A

FORM 4/A SUBMISSION

Company: Atara Biotherapeutics, Inc.
Filed: February 12, 2019
Period of Report: February 6, 2019
Accession Number: 0001209191-19-009507

View Document ↗ View on SEC.gov ↗